{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:12:26Z","timestamp":1745381546484,"version":"3.40.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"China Postdoctoral Program","award":["2023M741256"],"award-info":[{"award-number":["2023M741256"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304141","82273628"],"award-info":[{"award-number":["82304141","82273628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00535-025-02220-4","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T21:10:52Z","timestamp":1740431452000},"page":"621-631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention"],"prefix":"10.1007","volume":"60","author":[{"given":"Mengyang","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiyang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1071-3247","authenticated-orcid":false,"given":"Hongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"2220_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","journal-title":"J Hepatol"},{"key":"2220_CR2","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","volume":"72","author":"JM Paik","year":"2020","unstructured":"Paik JM, Golabi P, Younossi Y, et al. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 2020;72:1605\u201316.","journal-title":"Hepatology"},{"key":"2220_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335\u201347.","journal-title":"Hepatology"},{"key":"2220_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322.","journal-title":"Nat Med"},{"key":"2220_CR5","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/jcb.30247","volume":"123","author":"CM Flessa","year":"2022","unstructured":"Flessa CM, Kyrou I, Nasiri-Ansari N, et al. Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD\/MAFLD). J Cell Biochem. 2022;123:1585\u2013606.","journal-title":"J Cell Biochem"},{"key":"2220_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.atherosclerosis.2022.07.010","volume":"355","author":"Z Wang","year":"2022","unstructured":"Wang Z, Ye M, Zhang XJ, et al. Impact of NAFLD and its pharmacotherapy on lipid profile and CVD. Atherosclerosis. 2022;355:30\u201344.","journal-title":"Atherosclerosis"},{"key":"2220_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. 2018;69:896\u2013904.","journal-title":"J Hepatol"},{"key":"2220_CR8","doi-asserted-by":"crossref","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"2220_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14:889\u2013919.","journal-title":"Hepatol Int"},{"key":"2220_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"2220_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/metabo13040536","volume":"13","author":"R Forlano","year":"2023","unstructured":"Forlano R, Sigon G, Mullish BH, et al. Screening for NAFLD-current knowledge and challenges. Metabolites. 2023;13:536.","journal-title":"Metabolites"},{"key":"2220_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1665-2681(19)31317-1","volume":"12","author":"A Said","year":"2013","unstructured":"Said A, Gagovic V, Malecki K, et al. Primary care practitioners survey of non-alcoholic fatty liver disease. Ann Hepatol. 2013;12:758\u201365.","journal-title":"Ann Hepatol"},{"key":"2220_CR13","doi-asserted-by":"publisher","first-page":"e743","DOI":"10.3399\/bjgp18X699377","volume":"68","author":"HC Standing","year":"2018","unstructured":"Standing HC, Jarvis H, Orr J, et al. GPs\u2019 experiences and perceptions of early detection of liver disease: a qualitative study in primary care. Br J Gen Pract. 2018;68:e743\u20139.","journal-title":"Br J Gen Pract"},{"key":"2220_CR14","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.cgh.2020.01.020","volume":"18","author":"S McHenry","year":"2020","unstructured":"McHenry S, Park Y, Browning JD, et al. Dallas steatosis index identifies patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2020;18:2073-80.e7.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2220_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","volume":"16","author":"NE Rich","year":"2018","unstructured":"Rich NE, Oji S, Mufti AR, et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:198-210.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2220_CR16","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.cgh.2021.05.035","volume":"20","author":"S McHenry","year":"2022","unstructured":"McHenry S, Park Y, Davidson NO. Validation of the Dallas steatosis index to predict nonalcoholic fatty liver disease in the UK biobank population. Clin Gastroenterol Hepatol. 2022;20:2638\u201340.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2220_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110870","volume":"203","author":"M Kouvari","year":"2023","unstructured":"Kouvari M, Mylonakis SC, Katsarou A, et al. The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: a multicenter study. Diabetes Res Clin Pract. 2023;203: 110870.","journal-title":"Diabetes Res Clin Pract"},{"key":"2220_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/ije\/dys053","volume":"42","author":"F Wang","year":"2013","unstructured":"Wang F, Zhu J, Yao P, et al. Cohort profile: the Dongfeng-Tongji cohort study of retired workers. Int J Epidemiol. 2013;42:731\u201340.","journal-title":"Int J Epidemiol"},{"key":"2220_CR19","unstructured":"World Health Organization. Regional Office for the Western Pacific. 2000. The Asia-Pacific perspective : redefining obesity and its treatment. Sydney : Health Communications Australia. https:\/\/iris.who.int\/handle\/10665\/206936 Accessed May 1, 2024"},{"key":"2220_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u20135.","journal-title":"Cancer"},{"key":"2220_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42:503\u20138.","journal-title":"Dig Liver Dis"},{"key":"2220_CR22","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cgh.2016.03.034","volume":"14","author":"MT Long","year":"2016","unstructured":"Long MT, Pedley A, Colantonio LD, et al. Development and validation of the framingham steatosis index to identify persons with hepatic steatosis. Clin Gastroenterol Hepatol. 2016;14:1172-80.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2220_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"key":"2220_CR24","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1111\/liv.15046","volume":"42","author":"T Nakatsuka","year":"2022","unstructured":"Nakatsuka T, Tateishi R, Koike K. Changing clinical management of NAFLD in Asia. Liver Int. 2022;42:1955\u201368.","journal-title":"Liver Int"},{"key":"2220_CR25","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1007\/s10620-022-07415-w","volume":"67","author":"JV DiBattista","year":"2022","unstructured":"DiBattista JV, Burkholder DA, Lok AS, et al. Accuracy of non-invasive indices for diagnosing hepatic steatosis compared to imaging in a real-world cohort. Dig Dis Sci. 2022;67:5300\u20138.","journal-title":"Dig Dis Sci"},{"key":"2220_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/apt.15673","volume":"51","author":"C Estes","year":"2020","unstructured":"Estes C, Chan HLY, Chien RN, et al. Modelling NAFLD disease burden in four Asian regions-2019-2030. Aliment Pharmacol Ther. 2020;51:801\u201311.","journal-title":"Aliment Pharmacol Ther"},{"key":"2220_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","volume":"16","author":"M Alexander","year":"2018","unstructured":"Alexander M, Loomis AK, Fairburn-Beech J, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018;16:130.","journal-title":"BMC Med"},{"key":"2220_CR28","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal F, Shubrook JH, Adams LA, et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology. 2021;161:1657\u201369.","journal-title":"Gastroenterology"},{"key":"2220_CR29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1097\/HEP.0000000000000023","volume":"77","author":"E Vilar-Gomez","year":"2023","unstructured":"Vilar-Gomez E, Vuppalanchi R, Gawrieh S, et al. CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology. 2023;77:1241\u201352.","journal-title":"Hepatology"},{"key":"2220_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/1751-2980.12685","volume":"20","author":"JG Fan","year":"2019","unstructured":"Fan JG, Wei L, Zhuang H. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). J Dig Dis. 2019;20:163\u201373.","journal-title":"J Dig Dis"},{"key":"2220_CR31","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","volume":"24","author":"S Leoni","year":"2018","unstructured":"Leoni S, Tovoli F, Napoli L, et al. Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol. 2018;24:3361\u201373.","journal-title":"World J Gastroenterol"},{"key":"2220_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/jgh.13856","volume":"33","author":"S Chitturi","year":"2018","unstructured":"Chitturi S, Wong VW, Chan WK, et al. The Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 2: management and special groups. J Gastroenterol Hepatol. 2018;33:86\u201398.","journal-title":"J Gastroenterol Hepatol"},{"key":"2220_CR33","first-page":"1246518","volume":"2019","author":"Z Tang","year":"2019","unstructured":"Tang Z, Pham M, Hao Y, et al. Sex, age, and BMI modulate the association of physical examinations and blood biochemistry parameters and NAFLD: a retrospective study on 1994 cases observed at Shuguang hospital. China Biomed Res Int. 2019;2019:1246518.","journal-title":"China Biomed Res Int"},{"key":"2220_CR34","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G Marchesini","year":"2001","unstructured":"Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844\u201350.","journal-title":"Diabetes"},{"key":"2220_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/CM9.0000000000002753","volume":"137","author":"M Yuan","year":"2024","unstructured":"Yuan M, He J, Hu X, et al. Hypertension and NAFLD risk: Insights from the NHANES 2017\u20132018 and Mendelian randomization analyses. Chin Med J. 2024;137:457\u201364.","journal-title":"Chin Med J"},{"key":"2220_CR36","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019;25:6053\u201362.","journal-title":"World J Gastroenterol"},{"key":"2220_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jgh.13857","volume":"33","author":"VW Wong","year":"2018","unstructured":"Wong VW, Chan WK, Chitturi S, et al. Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment. J Gastroenterol Hepatol. 2018;33:70\u201385.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02220-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-025-02220-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02220-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:57:59Z","timestamp":1745301479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-025-02220-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1007\/s00535-025-02220-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"type":"print","value":"0944-1174"},{"type":"electronic","value":"1435-5922"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}